ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Diabetes-Induced Renal Injury in Rats Is Attenuated by Suramin

Korrapati, Midhun C.; Shaner, Brooke E.; Neely, Benjamin A.; Alge, Joseph L.; Arthur, John M.; Schnellmann, Rick G.*
Journal of Pharmacology and Experimental Therapeutics2012-10DOI: 10.1124/jpet.112.196964
25被引5阅读
引用收藏
分享

摘要

Progression of hyperglycemia-induced renal injury is a contributing factor for diabetic nephropathy (DN)-induced end-stage renal disease (ESRD), and development of novel therapeutic strategies that act early to prevent progression of DN and ESRD are important. We examined the efficacy and mechanism(s) of suramin on hyperglycemia-induced renal injury before development of overt histological damage. Two groups of male Sprague-Dawley rats received streptozotocin (STZ) and one group received saline. Three weeks later, one STZ group received suramin (10 mg/kg). All animals were euthanized 1 week later (4 weeks). Although there was a decrease in creatinine clearance between control and STZ +/- suramin rats, there was no difference in creatinine clearance between STZ rats +/- suramin intervention. Liquid chromatography-tandem mass spectroscopy-based analysis revealed increases in urinary proteins that are early indicators of DN (e.g., cystatin C, clusterin, cathepsin B, retinol binding protein 4, and peroxiredoxin-1) in the STZ group, which were blocked by suramin. Endothelial intracellular adhesion molecule-1 (ICAM-1) activation, leukocyte infiltration, and inflammation; transforming growth factor-beta 1 (TGF-beta 1) signaling; TGF-beta 1/SMAD-3-activated fibrogenic markers fibronectin-1, alpha-smooth muscle actin, and collagen 1A2; activation of proinflammatory and profibrotic transcription factors nuclear factor-kappa B (NF-kappa B) and signal transducer and activator of transcription factor-3 (STAT-3), respectively, were all increased in STZ rats and suramin blocked these changes. In conclusion, delayed administration of suramin attenuated 1) urinary markers of DN, 2) inflammation by blocking NF-kappa B activation and ICAM-1-mediated leukocyte infiltration, and 3) fibrosis by blocking STAT-3 and TGF-beta 1/SMAD-3 signaling. These results support the potential use of suramin in DN.

学科与关键词

关键词
GELATINASE-ASSOCIATED LIPOCALINTGF-BETAPROTEOMIC ANALYSISSTATISTICAL-MODELGENE-EXPRESSIONEARLY BIOMARKERCYSTATIN CNEPHROPATHYACTIVATIONFIBROSIS
相关
加载中…
  • Anti-diabetic and Renoprotective Effects of Bisacurone in Streptozotocin-induced Diabetic Nephropathy Rats
    Wu, Rui; Xia, Nan*Latin American Journal of Pharmacy, 2023, 42(8): 1685-1692.
  • Dapagliflozin attenuates renal fibrosis by suppressing angiotensin II/TGFβ signaling in diabetic mice
    Jiang, Mingwang; Yang, Zhichen; Lyu, Lu*; Shi, Meng*JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38(2): 108687.
  • Xiao-Shen-Formula, a Traditional Chinese Medicine, Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase Expression.
    An, Xiaofei; Zhang, Maoxiang; Zhou, Sisi; Lu, Tian; Chen, Yongjun; Yao, LinFrontiers in Physiology, 2018, 9: 1195.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Pharmacology and Experimental Therapeutics
发表日期
2012-10
卷期
第 343 卷, 第 1 期
页码
34-43
DOI
10.1124/jpet.112.196964
语言
ENGLISH
成果收录
SCIE
资助标注
National Institutes of Health National Institute of General Medical Sciences [GM084147]; National Institutes of Health National Center for Research Resources [UL1-RR029882, C06-RR015455]; Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs; South Carolina Clinical and Translational Research Institute; Medical University of South Carolina

作者

  • K

    Korrapati, Midhun C. (第一作者)

  • S

    Shaner, Brooke E.

查看全部 6 位作者收起作者
  • N

    Neely, Benjamin A.

  • A

    Alge, Joseph L.

  • A

    Arthur, John M.

  • S

    Schnellmann, Rick G. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417